Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells.
Interleukin-7 (IL-7) is produced by bone marrow and lymphoid stromal cells and is involved in the synthesis, survival and homeostasis of T cells. These attributes are the basis for current strategies to utilize IL-7 as an immune modulator for several clinical conditions to replenish depleted T-cell numbers. Because we had previously determined that IL-7 can induce potent human immunodeficiency virus replication in the otherwise non-permissive CD4(+) naive T-cell compartment, we evaluated here the impact of IL-7 on the phenotype and functional potential of naive CD4(+) T cells in an attempt to understand the mechanism of this induction. We demonstrate that IL-7 mediated the up-regulation of CD25, CD95 and human leucocyte antigen-DR, while it did not alter the expression of CD45RO, CD69, CD40, or CD154. Examination of the cytokine profile of IL-7-treated naive T cells using a Type1/Type2 Proteome Array indicated a remarkable IL-7-mediated induction of interferon-gamma production, while the other cytokines evaluated (IL-2, IL-12, tumour necrosis factor-alpha, IL-4, IL-5, IL-10 and IL-13) were not affected. Intracellular staining of IL-7-treated naive T cells for interferon-gamma verified the Proteome data. IL-7 did not induce cell cycle proliferation of naive CD4(+) T cells, as evaluated by 7-AAD/pyronin immunostaining and carboxyfluorescein diacetate succinimidyl ester dye tracking. IL-7 treatment of naive CD4(+) T cells induced their ability to prime monocytes, as was indicated by induction of CD80 and CD86 expression on monocytes cocultured with IL-7-treated naive CD4(+) T cells. Collectively, these data indicate that IL-7 signalling is sufficient to phenotypically and functionally prime human CD4(+) naive T cells independent of antigen stimulation.
Managlia
Elizabeth Z
EZ
Department of Immunology and Microbiology, Rush University Medical Center, Chicago, IL 60612, USA.
Landay
Alan
A
Al-Harthi
Lena
L
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002453:Cell Cycle / Q000276:immunology; D002478:Cells, Cultured; D018920:Coculture Techniques; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D016130:Immunophenotyping; D015851:Interleukin-7 / Q000276:immunology*; D017493:Leukocyte Common Antigens / Q000032:analysis; D015398:Signal Transduction / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*
D016207:Cytokines; D015851:Interleukin-7; D017493:Leukocyte Common Antigens
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9277-82
11470908
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8104-9
10393955
Blood. 2001 Oct 1;98(7):2256-65
11568014
Immunity. 2001 Oct;15(4):671-82
11672548
Scand J Immunol. 2001 Nov;54(5):501-5
11696202
J Immunol. 2001 Dec 15;167(12):6869-76
11739504
J Exp Med. 2001 Dec 17;194(12):1711-9
11748273
Nat Med. 2002 Apr;8(4):379-85
11927944
Blood. 2002 Apr 15;99(8):2851-8
11929775
Blood. 2002 May 1;99(9):3310-8
11964298
Blood. 2002 Jun 1;99(11):3892-904
12010786
Blood. 2002 Oct 1;100(7):2642-9
12239180
Immunity. 2002 Oct;17(4):425-36
12387737
J Hematother Stem Cell Res. 2002 Oct;11(5):803-7
12427286
J Neuroimmunol. 1999 Dec;100(1-2):115-23
10695722
Blood. 2000 Aug 1;96(3):885-93
10910901
J Immunol. 2000 Aug 15;165(4):1733-7
10925249
Nat Med. 2001 Jan;7(1):73-9
11135619
Nature. 2001 Mar 1;410(6824):106-11
11242051
Blood. 2001 Mar 15;97(6):1525-33
11238086
Nat Immunol. 2000 Nov;1(5):426-32
11062503
Blood. 2001 May 15;97(10):2983-90
11342421
J Virol. 2002 Dec;76(24):13077-82
12438635
Blood. 2002 Dec 15;100(13):4676-7; author reply 4677-8
12453882
Nat Immunol. 2003 Mar;4(3):225-34
12563257
Blood. 2003 Mar 15;101(6):2167-74
12446448
J Immunol. 2003 Jul 1;171(1):61-8
12816983
Blood. 2003 Jul 15;102(2):497-505
12649146
Immunity. 2003 Sep;19(3):413-23
14499116
Top HIV Med. 2003 Sep-Oct;11(5):160-3
14555803
J Virol. 2004 Jun;78(11):5535-45
15140950
J Virol. 2004 Jun;78(11):6033-42
15141001
J Immunol. 2004 Jun 1;172(11):6675-83
15153483
J Exp Med. 1989 Mar 1;169(3):707-16
2522498
J Immunol. 1990 Feb 1;144(3):938-41
2295821
Nature. 1992 Nov 19;360(6401):264-5
1436108
Immunol Today. 1993 Jan;14(1):25-9
8442858
J Immunol. 1996 May 15;156(10):3587-90
8621891
Eur J Immunol. 1996 Jun;26(6):1273-7
8647204
J Immunol. 1996 Mar 15;156(6):2324-30
8690924
Hum Immunol. 1996 Jun-Jul;48(1-2):68-76
8824575
Cell. 1997 Jun 27;89(7):1011-9
9215624
Cell. 1997 Jun 27;89(7):1033-41
9215626
J Virol. 1998 Apr;72(4):3161-8
9525642
Eur J Immunol. 1998 Oct;28(10):3057-65
9808174
J Immunol. 1998 Dec 1;161(11):5909-17
9834071
J Exp Med. 1999 Feb 1;189(3):563-74
9927518
J Exp Med. 1999 Jun 7;189(11):1735-46
10359577
J Immunol. 1999 Aug 1;163(3):1315-20
10415029
J Immunol. 1999 Aug 15;163(4):1817-26
10438914
Nature. 1999 Oct 14;401(6754):708-12
10537110
Immunology. 1999 Nov;98(3):400-5
10583600
Immunity. 1999 May;10(5):525-35
10367898
J Immunol. 2001 Aug 15;167(4):1970-6
11489977